会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • PROPANE-1,3-DIOL DERIVATIVES, A METHOD FOR THEIR PRODUCTION AND A PHARMACEUTICAL COMPOSITION
    • 丙-1,3-二醇衍生物,其生产方法和药物组合物
    • WO1987003281A1
    • 1987-06-04
    • PCT/DK1986000128
    • 1986-11-20
    • LEO PHARMACEUTICAL PRODUCTS LTD. A/SGRUE-SORENSEN, GunnarNIELSEN, Christian, Kaergaard
    • LEO PHARMACEUTICAL PRODUCTS LTD. A/S
    • C07C93/04
    • C07D277/24C07C271/06C07C333/02
    • A derivative of 2-methylenepropane-1,3-diol of general formula (I), where O-A and O-A , which can be the same or different, each represents O, O-C(O), O-C(O)NH, O-C(S)NH or O-C(O)O, R represents an alkyl or alkenyl group of 10 - 22 carbon atoms, n is an integer from 1 to 11, B represents a quaternary ammonium group, either NR R R , or N(Het), where R , R and R are similar or different alkyl groups of 1 - 4 carbon atoms, or two or all of R , R and R may be incorporated into a cyclic or bicyclic structure, which may contain additional hetero atoms; X means the anion of a pharmaceutically acceptable inorganic or organic acid; and R and R are the same or different, and represent hydrogen or alkyl groups of 1 - 4 carbon atoms. The present compounds have been shown to possess a PAF antagonistic effect and an inhibitory effect on the growth of tumor cells, and are thus valuable in the human and veterinary practice as platelet aggregation inhibitors, anti-thrombotic agents, anti-asthmatic agents, anti-allergic agents, anti-inflammatory agents, anti-hypotensive agents, anti-ulcer agents, anti-psoriatic agents, anti-graft rejection agents, anti-conception agents and anti-tumor agents.
    • 通式(I)的2-亚甲基丙烷-1,3-二醇的衍生物,其中OA 1和OA 2可以相同或不同,各自表示O,OC(O),OC(O )NH,OC(S)NH或OC(O)O,R 1表示10-22个碳原子的烷基或烯基,n是1至11的整数,B +表示季铵基 NR 4 R 5 R 6或N(Het),其中R 4,R 5和R 6是相同或不同的1-4个碳原子的烷基,或 R 4,R 5和R 6中的两个或全部可以并入环状或双环结构,其可以含有另外的杂原子; 是指药学上可接受的无机酸或有机酸的阴离子; R 2和R 3相同或不同,代表氢或1-4个碳原子的烷基。 本发明化合物已被证明具有PAF拮抗作用和对肿瘤细胞生长的抑制作用,因此在人和兽医学实践中作为血小板聚集抑制剂,抗血栓形成剂,抗哮喘药,抗 - 过敏剂,抗炎剂,抗低血压剂,抗溃疡剂,抗牛皮癣剂,抗移植物排斥剂,抗受孕剂和抗肿瘤剂。
    • 6. 发明申请
    • NOVEL VITAMIN D ANALOGUES
    • 新维生素D类似物
    • WO1991015475A1
    • 1991-10-17
    • PCT/DK1991000091
    • 1991-03-22
    • LEO PHARMACEUTICAL PRODUCTS LTD. A/S (LOVENS ...CALVERLEY, Martin, JohnGRUE-SORENSEN, GunnarBINDERUP, Ernst, Torndal
    • LEO PHARMACEUTICAL PRODUCTS LTD. A/S (LOVENS ...
    • C07C401/00
    • C07C401/00
    • The invention relates to compounds of formula (I) in which formula X is hydrogen or hydroxy; Y is oxygen or sulphur or oxidized sulphur (S(O) or S(O2)); R and R , which may be the same or different, stand for hydrogen or C1-C6 hydrocarbyl; or R and R , taken together with the carbon atom (starred in formula I) bearing the group X, can form a C3-C8 carbocyclic ring; Q is a C1-C8 hydrocarbylene diradical. R is hydrogen or C1-C6 hydrocarbyl. R , R and/or Q may be optionally substituted with one or more deuterium or fluorine atoms. n is 0 or 1. The present compounds, which find use both in the human and veterinary practice, show an antiinflammatory and immunomodulating effects as well as strong activity in inducing differentiation and inhibiting undesirable proliferation of certain cells, including cancer cells and skin cells.
    • 本发明涉及式(I)化合物,其中式X为氢或羟基; Y是氧或硫或氧化硫(S(O)或S(O 2)); R 1和R 2可以相同或不同,代表氢或C 1 -C 6烃基; 或R 1和R 2与带有基团X的碳原子(以式I表示的原子)一起可以形成C 3 -C 8碳环; Q是C1-C8亚烃基双基。 R 3是氢或C 1 -C 6烃基。 R 1,R 2和/或Q可任选被一个或多个氘或氟原子取代。 n是0或1.本发明化合物在人和兽医学实践中都有用,显示出抗炎和免疫调节作用,以及在诱导分化和抑制某些细胞(包括癌细胞和皮肤细胞)的不期望的增殖的强烈活性。